Nectar Lifescience Ltd Share Price
(NECLIFE)
₹22.95
as on 04:01PM, 28 Mar 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -10.04 % |
3 Month Return | -39.95 % |
1 Year Return | -32.99 % |
Market Stats | |
Previous Close | ₹23.61 |
Open | ₹24.00 |
Volume | 23.41L |
Upper Circuit | ₹24.79 |
Lower Circuit | ₹22.42 |
Market Cap | ₹514.68Cr |
P/E Ratio
30.2
PEG Ratio
75.49
Market Cap
₹514.68 Cr
P/B Ratio
0.63
EPS
0.22
Dividend Yield
0Sector
Pharmaceuticals
ROE
0.47
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, 0.59 Cr → 7.84 Cr (in ₹), with an average increase of 51.9% per quarter
Revenue Rich
Revenue is up for the last 3 quarters, 359.85 Cr → 455.56 Cr (in ₹), with an average increase of 11.0% per quarter
Retail Holding Up
Retail Investor have increased holdings from 32.54% to 54.72% in Dec 2024 quarter
Promoter Holding Up
Promoters have increased holdings from 44.35% to 44.53% in Dec 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.8% return, outperforming this stock by 135.5%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 61.9% return, outperforming this stock by 94.9%
FII Holding Down
Foreign Institutions have decreased holdings from 2.57% to 0.73% in Dec 2024 quarter
Price Dip
In the last 1 month, NECLIFE stock has moved down by -10.0%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.53% | 0.40 | |
Foreign Institutions | 0.73% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 54.72% | 68.14 | |
Others | 0.02% |
Nectar Lifescience Ltd in the last 5 years
Lowest (-284.58x)
December 21, 2023
Today (30.20x)
March 28, 2025
Industry (53.18x)
March 28, 2025
Highest (403.33x)
August 26, 2020
Nectar Lifescience Ltd’s net profit jumped 399.36% since last year same period to ₹7.84Cr in the Q3 2024-2025. On a quarterly growth basis, Nectar Lifescience Ltd has generated 40% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 - translating a dividend yield of 0.22%.
Read More about DividendsBearish
Neutral
Bullish
Nectar Lifescience Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹514.68 Cr | 28.32% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
NA | ₹22.46 Cr | 78.35% | 0.50 | NA | NA | |
NA | ₹1,923.52 Cr | 980.26% | 0.54 | ₹36 Cr | ₹295 Cr | |
NA | ₹901.74 Cr | 648.5% | 0.65 | ₹23 Cr | ₹307 Cr | |
NA | ₹117.60 Cr | 31.24% | 0.72 | -₹10 Cr | ₹368 Cr |
Organisation | Nectar Lifescience Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Nectar Lifescience Ltd share price today stands at ₹22.95, Open: ₹24, Previous Close: ₹23.61, High: ₹24.54, Low: ₹22.75, 52 Week High: ₹56.5, 52 Week Low: ₹22.1.
Today's traded volume of Nectar Lifescience Ltd(NECLIFE) is 23.41L.
Today's market capitalisation of Nectar Lifescience Ltd(NECLIFE) is ₹514.68Cr.
Nectar Lifescience Ltd (NECLIFE) share price is ₹22.95. It is down -59.38% from its 52 Week High price of ₹56.5
Nectar Lifescience Ltd (NECLIFE) share price is ₹22.95. It is up 3.85% from its 52 Week Low price of ₹22.1